Catalyst
Slingshot members are tracking this event:
Teva's Generic Version of Daiichi Sankyo's (DSNKY) Tribenzor Approved by FDA for Hypertension
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 07, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Generic, Tribenzor, Hypertension, Blood Pressure Medication
